Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous NK Cells to Prevent HCC Recurrence
NCT02725996Phase 2Unknown
- Sponsor
- Southwest Health System
- Start
- Apr 2016
- Primary completion
- Apr 2018
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of troculeucel in hepatocellular carcinoma (HCC), sponsored by Southwest Health System. Status: unknown.
02
Drugs
troculeucel
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02725996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725996.